Stay updated on Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2F_TvYEpsvCnhMl4oGTC2wg3vohxg.uncropped.jpg&w=3840&q=75)
Latest updates to the Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.3%
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe website has been updated from version v2.10.0 to v2.10.2 on 2024-08-13, indicating new features or improvements.SummaryDifference0.7%
- Check30 days agoChange DetectedNew content was added on August 6, 2024, following the deletion of previous content on July 30, 2024.SummaryDifference0.7%
- Check37 days agoChange DetectedNew content was added on July 30, 2024, following the deletion of previous content on July 24, 2024.SummaryDifference0.3%
- Check43 days agoChange DetectedNew content was added on July 24, 2024, following the deletion of previous content on July 16, 2024.SummaryDifference0.3%
- Check44 days agoChange DetectedThe website has been updated to version 2.10.0, introducing new features for viewing and comparing study record versions.SummaryDifference6%
Stay in the know with updates to Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial page.